Table 1.
Sociodemographic characteristics and adjusted odds ratios (95% confidence intervals) for the two outcomes: late treatment initiation and treatment initiation with advanced disease
| Late treatment initiation | Treatment initiation with advanced disease | ||||||
|---|---|---|---|---|---|---|---|
| Total | No | Yes | Odds Ratio (95%CI) | No | Yes | Odds Ratio (95%CI) | |
| Total | 3226 | 1150 (35.6) | 2076 (64.4) | 1803 (55.9) | 1423 (44.1) | ||
| Exposure of interest | |||||||
| Educational level | |||||||
| Tertiary | 525 (16.4) | 242 (46.1) | 283 (53.9) | Ref. | 366 (69.7) | 159 (30.3) | Ref. |
| Secondary | 1251 (39.2) | 480 (38.4) | 771 (61.6) | 1.35 (1.09–1.67) | 751 (60) | 500 (40) | 1.51 (1.21–1.88) |
| Basic | 540 (16.9) | 163 (30.2) | 377 (69.8) | 1.61 (1.23–2.1) | 268 (49.6) | 272 (50.4) | 2.07 (1.59–2.71) |
| Incomplete basic | 876 (27.4) | 249 (28.4) | 627 (71.6) | 1.89 (1.47–2.43) | 399 (45.5) | 477 (54.5) | 2.53 (1.97–3.26) |
| Covariates | |||||||
| Age at treatment initiation | |||||||
| Median (IQR) | 36.6 (30.8,44.5) | 35.5 (29.9,44) | 37.2 (31.3,44.7) | – | 35.5 (30.1,43.5) | 38 (31.7,45.2) | – |
| Gender/Sexual orientationa | |||||||
| Cis women | 938 (29.1) | 349 (37.2) | 589 (62.8) | Ref. | 559 (59.6) | 379 (40.4) | Ref. |
| Cis MSM | 1205 (37.4) | 479 (39.8) | 726 (60.2) | 1.23 (1.01–1.49) | 740 (61.4) | 465 (38.6) | 1.28 (1.06–1.55) |
| Cis heterosexual men | 772 (23.9) | 196 (25.4) | 576 (74.6) | 1.76 (1.42–2.18) | 35 (43.4) | 437 (56.6) | 1.96 (1.61–2.39) |
| Cis men (unknown exposure) | 311 (9.6) | 126 (40.5) | 185 (59.5) | 1.18 (0.9–1.56) | 169 (54.3) | 142 (45.7) | 1.62 (1.24–2.12) |
| Skin color/race | |||||||
| White | 1378 (43.3) | 517 (37.5) | 861 (62.5) | Ref. | 816 (59.2) | 562 (40.8) | Ref. |
| Black | 697 (21.9) | 217 (31.1) | 480 (68.9) | 1.34 (1.09–1.65) | 347 (49.8) | 350 (50.2) | 1.34 (1.1–1.63) |
| Mixed (pardo) | 1109 (34.8) | 404 (36.4) | (63.6) | 1.08 (0.91–1.28) | 622 (56.1) | 487 (43.9) | 1.06 (0.9–1.26) |
| State of origin | |||||||
| Rio de Janeiro | 2511 (79.6) | 914 (36.4) | 1597 (63.6) | Ref. | 1418 (56.5) | 1093 (43.5) | Ref. |
| Other | 645 (20.4) | 212 (32.9) | 433 (67.1) | 1.07 (0.88–1.3) | 347 (53.8) | 298 (46.2) | 1.02 (0.85–1.22) |
| Year of treatment initiation | |||||||
| Median (IQR) | 2011 (2008,2014) | 2013 (2010,2015) | 2011 (2008,2013) | 0.86 (0.83–0.88) | 2012 (2009,2014) | 2011 (2008,2014) | 0.94 (0.91–0.97) |
MSM men who have sex with men, RJ Rio de Janeiro State, ART antiretroviral treatment, CI confidence interval
a The gender/sexual orientation variable combines information of a person’s gender identity and sexual orientation as it pertains to the probable mode of HIV acquisition thus categorizing the study population into cis-women, cis-men who have sex with men, heterosexual cis-men and other cis-men for whom their mode of HIV acquisition is unknown